NCT05369481Status unknown
Comparison Between Efficacy of Topical Sildenafil 2% and Topical Minoxidil 5% in Treatment of Androgenic Alopecia
Comparative Study Between the Efficacy of Topical Sildenafil 2% and Topical Minoxidil 5% in the Treatment of Male Androgenic Alopecia
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Status unknown
- Declared phase
- Not applicable (NA in the registry)
- Sponsor
- Mohammed Abd El Mawgoud Amer
- Participants (registry)
- 50
- Start
- March 2022
- Primary completion
- August 2022
- Study completion
- September 2022
- Last registry update
- May 2022
- Countries
- Egypt
Conditions studied: Androgenic Alopecia
Interventions: Sildenafil 2%, Local Scalp Injection, Minoxidil 5 %, Local Scalp Injection
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.